| Primary |
| Hypertension |
59.0% |
| Cardiac Failure |
4.6% |
| Drug Use For Unknown Indication |
3.6% |
| Essential Hypertension |
3.6% |
| Atrial Fibrillation |
3.0% |
| Hypertensive Heart Disease |
3.0% |
| Type 2 Diabetes Mellitus |
3.0% |
| Depression |
2.4% |
| Metastatic Renal Cell Carcinoma |
2.4% |
| Myocardial Infarction |
2.4% |
| Dyslipidaemia |
1.8% |
| Arrhythmia |
1.5% |
| Diabetes Mellitus |
1.5% |
| Parkinson's Disease |
1.5% |
| Bacteraemia |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Bradycardia |
0.9% |
| Constipation |
0.9% |
| Gout |
0.9% |
|
| White Blood Cell Count Increased |
13.3% |
| Hypotension |
8.9% |
| Orthostatic Hypotension |
7.8% |
| Syncope |
7.8% |
| Bradycardia |
5.6% |
| Renal Failure Acute |
5.6% |
| Drug Interaction |
4.4% |
| Hepatitis |
4.4% |
| Suicide Attempt |
4.4% |
| Thrombocytopenia |
4.4% |
| Confusional State |
3.3% |
| Cytolytic Hepatitis |
3.3% |
| Haemolytic Anaemia |
3.3% |
| Pregnancy |
3.3% |
| Pyrexia |
3.3% |
| Respiratory Distress |
3.3% |
| Sinus Bradycardia |
3.3% |
| Skin Discolouration |
3.3% |
| Torsade De Pointes |
3.3% |
| Vertigo |
3.3% |
|
| Secondary |
| Hypertension |
34.6% |
| Drug Use For Unknown Indication |
19.8% |
| Product Used For Unknown Indication |
16.6% |
| Type 2 Diabetes Mellitus |
6.1% |
| Diabetes Mellitus |
3.2% |
| Hiv Infection |
2.7% |
| Atrial Fibrillation |
2.2% |
| Arrhythmia |
2.1% |
| Myocardial Ischaemia |
1.9% |
| Rheumatoid Arthritis |
1.4% |
| Hypercholesterolaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Angina Pectoris |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Convulsion |
1.0% |
| Depression |
1.0% |
| Prophylaxis Of Neural Tube Defect |
1.0% |
| Ingrowing Nail |
0.7% |
| Tachycardia |
0.7% |
| Arthralgia |
0.6% |
|
| Renal Failure Acute |
15.1% |
| Loss Of Consciousness |
8.5% |
| Tremor |
8.5% |
| Vomiting |
8.5% |
| Pollakiuria |
6.6% |
| Bradycardia |
5.7% |
| Syncope |
4.7% |
| Weight Decreased |
4.7% |
| Drug Interaction |
3.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.8% |
| Toxic Skin Eruption |
3.8% |
| Wheezing |
3.8% |
| Abdominal Pain |
2.8% |
| Hyperkalaemia |
2.8% |
| Hypoglycaemia |
2.8% |
| Oedema Peripheral |
2.8% |
| Orthostatic Hypotension |
2.8% |
| Pruritus |
2.8% |
| Rhabdomyolysis |
2.8% |
| Sinus Arrhythmia |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.2% |
| Hypertension |
23.8% |
| Drug Use For Unknown Indication |
8.1% |
| Diabetes Mellitus |
4.5% |
| Rheumatoid Arthritis |
4.0% |
| Prophylaxis |
3.5% |
| Pain |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.7% |
| Atrial Fibrillation |
2.6% |
| Osteoporosis |
2.5% |
| Type 2 Diabetes Mellitus |
2.1% |
| Cardiac Failure |
2.1% |
| Depression |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Non-small Cell Lung Cancer |
1.7% |
| Multiple Allergies |
1.5% |
| Coronary Artery Disease |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Cardiac Disorder |
1.2% |
| Hepatitis C |
1.2% |
|
| Renal Failure Acute |
6.8% |
| Myocardial Infarction |
6.4% |
| Vomiting |
6.4% |
| Hypertension |
6.0% |
| Thrombocytopenia |
6.0% |
| Weight Decreased |
6.0% |
| International Normalised Ratio Increased |
5.6% |
| Pyrexia |
5.6% |
| Renal Failure |
5.6% |
| Diarrhoea |
5.1% |
| Hyponatraemia |
4.7% |
| Anaemia |
4.3% |
| Death |
4.3% |
| Gamma-glutamyltransferase Increased |
4.3% |
| Abdominal Pain |
3.8% |
| Fall |
3.8% |
| Headache |
3.8% |
| Oedema Peripheral |
3.8% |
| Pain In Extremity |
3.8% |
| Respiratory Failure |
3.8% |
|
| Interacting |
| Hypertension |
32.1% |
| Cardiac Failure |
14.3% |
| Renal Transplant |
14.3% |
| Blood Pressure Abnormal |
7.1% |
| Convulsion |
7.1% |
| Gout |
7.1% |
| Ingrowing Nail |
7.1% |
| Pain |
7.1% |
| Product Used For Unknown Indication |
3.6% |
|
| Septic Shock |
26.7% |
| Drug Interaction |
13.3% |
| Malaise |
13.3% |
| Cardio-respiratory Arrest |
6.7% |
| Dizziness |
6.7% |
| Heart Rate Decreased |
6.7% |
| Palpitations |
6.7% |
| Renal Failure Acute |
6.7% |
| Splenomegaly |
6.7% |
| Syncope |
6.7% |
|
